The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

Despite a high initial response rate to first-line platinum/paclitaxel chemotherapy, most women with epithelial ovarian cancer relapse with recurrent disease that becomes refractory to further cytotoxic treatment. We have previously shown that the E3 ubiquitin ligase, EDD, a regulator of DNA damage...

詳細記述

保存先:
書誌詳細
主要な著者: O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2008
主題:
Molecular Diagnostics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2275489/
https://ncbi.nlm.nih.gov/pubmed/18349819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604281
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料